{
  "cik": 1628171,
  "cik_padded": "0001628171",
  "entityName": "Revolution Medicines, Inc.",
  "fiscal_years": [
    {
      "accn": "0001193125-26-071563",
      "filed": "2026-02-25",
      "fiscal_year": 2025,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 15990000.0,
        "cash": 383745000.0,
        "eps_diluted": -5.95,
        "free_cash_flow": -913731000.0,
        "net_income": -1131301000.0,
        "operating_cash_flow": -897741000.0,
        "operating_income": -1182369000.0,
        "stockholders_equity": 1631297000.0,
        "total_assets": 2354508000.0,
        "total_liabilities": 723211000.0
      },
      "period_end": "2025-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.4433349659810568,
        "roa_avg2y": -0.4605515907498134,
        "roa_period_end": -0.4804829713893518,
        "roe_avg2y": -0.5806753289682205,
        "roe_period_end": -0.6934978731647273
      }
    },
    {
      "accn": "0001193125-26-071563",
      "filed": "2026-02-25",
      "fiscal_year": 2024,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 10308000.0,
        "cash": 543064000.0,
        "eps_diluted": -3.58,
        "free_cash_flow": -567744000.0,
        "net_income": -600093000.0,
        "operating_cash_flow": -557436000.0,
        "operating_income": -689524000.0,
        "stockholders_equity": 2265204000.0,
        "total_assets": 2558301000.0,
        "total_liabilities": 293097000.0
      },
      "period_end": "2024-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.1293909952481101,
        "roa_avg2y": -0.2597801821036596,
        "roa_period_end": -0.23456700364812427,
        "roe_avg2y": -0.29334374216343656,
        "roe_period_end": -0.2649178617025222
      }
    },
    {
      "accn": "0001193125-26-071563",
      "filed": "2026-02-25",
      "fiscal_year": 2023,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 7729000.0,
        "cash": 696148000.0,
        "eps_diluted": -3.86,
        "free_cash_flow": -358301000.0,
        "net_income": -436367000.0,
        "operating_cash_flow": -350572000.0,
        "operating_income": -487185000.0,
        "stockholders_equity": 1826194000.0,
        "total_assets": 2061705000.0,
        "total_liabilities": 235511000.0
      },
      "period_end": "2023-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.12896274985023498,
        "roa_avg2y": -0.30370384547793994,
        "roa_period_end": -0.21165346157670473,
        "roe_avg2y": -0.34751144987102717,
        "roe_period_end": -0.2389488739969576
      }
    },
    {
      "accn": "0001193125-26-071563",
      "filed": "2026-02-25",
      "fiscal_year": 2022,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 10816000.0,
        "cash": 161412000.0,
        "eps_diluted": -3.08,
        "free_cash_flow": -235217000.0,
        "net_income": -248705000.0,
        "operating_cash_flow": -224401000.0,
        "operating_income": -258279000.0,
        "stockholders_equity": 685188000.0,
        "total_assets": 811930000.0,
        "total_liabilities": 126742000.0
      },
      "period_end": "2022-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.18497405091741245,
        "roa_avg2y": -0.32092665547467675,
        "roa_period_end": -0.3063133521362679,
        "roe_avg2y": -0.3862610618781819,
        "roe_period_end": -0.3629733737310052
      }
    },
    {
      "accn": "0000950170-25-027736",
      "filed": "2025-02-26",
      "fiscal_year": 2021,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 6528000.0,
        "cash": 108497000.0,
        "eps_diluted": -2.57,
        "free_cash_flow": -153708000.0,
        "net_income": -187091000.0,
        "operating_cash_flow": -147180000.0,
        "operating_income": -188008000.0,
        "stockholders_equity": 602568000.0,
        "total_assets": 737988000.0,
        "total_liabilities": 135420000.0
      },
      "period_end": "2021-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.22473812084279285,
        "roa_avg2y": -0.28664405782490887,
        "roa_period_end": -0.2535149623029101,
        "roe_avg2y": -0.3473512036270334,
        "roe_period_end": -0.31048943853639754
      }
    },
    {
      "accn": "0000950170-24-020145",
      "filed": "2024-02-26",
      "fiscal_year": 2020,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 2933000.0,
        "cash": 104268000.0,
        "eps_diluted": -2.01,
        "free_cash_flow": -102997000.0,
        "net_income": -108159000.0,
        "operating_cash_flow": -100064000.0,
        "operating_income": -110697000.0,
        "stockholders_equity": 474676000.0,
        "total_assets": 567401000.0,
        "total_liabilities": 92725000.0
      },
      "period_end": "2020-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.195343771330339,
        "roa_avg2y": -0.2745396164633914,
        "roa_period_end": -0.19062180010257296,
        "roe_avg2y": -0.6715822938075516,
        "roe_period_end": -0.22785858143238757
      }
    },
    {
      "accn": "0000950170-23-004645",
      "filed": "2023-02-27",
      "fiscal_year": 2019,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 2589000.0,
        "cash": 16659000.0,
        "free_cash_flow": -52205000.0,
        "net_income": -47664000.0,
        "operating_cash_flow": -49616000.0,
        "operating_income": -54120000.0,
        "stockholders_equity": -152574000.0,
        "total_assets": 220529000.0,
        "total_liabilities": 67994000.0
      },
      "period_end": "2019-12-31",
      "ratio_units": {
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio"
      },
      "ratios": {
        "roa_period_end": -0.21613483940887593,
        "roe_avg2y": 0.3652469769651642
      }
    },
    {
      "accn": "0000950170-22-002297",
      "filed": "2022-02-28",
      "fiscal_year": 2018,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD"
      },
      "fundamentals": {
        "capex": 1499000.0,
        "cash": 69586000.0,
        "free_cash_flow": -286000.0,
        "net_income": -41789000.0,
        "operating_cash_flow": 1213000.0,
        "operating_income": -40329000.0,
        "stockholders_equity": -108422000.0
      },
      "period_end": "2018-12-31",
      "ratio_units": {
        "roe_avg2y": "ratio"
      },
      "ratios": {
        "roe_avg2y": 0.4745002526413798
      }
    },
    {
      "accn": "0001564590-21-010276",
      "filed": "2021-03-02",
      "fiscal_year": 2017,
      "form": "10-K",
      "fundamental_units": {
        "stockholders_equity": "USD"
      },
      "fundamentals": {
        "stockholders_equity": -67717000.0
      },
      "period_end": "2017-12-31",
      "ratios": {}
    }
  ],
  "latest_filing": {
    "accn": "0001193125-26-071563",
    "filed": "2026-02-25",
    "form": "10-K"
  },
  "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.",
  "schema_version": "1",
  "sic": "2836",
  "sic_description": "Biological Products, (No Diagnostic Substances)",
  "source_urls": {
    "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001628171.json",
    "sec_submissions": "https://data.sec.gov/submissions/CIK0001628171.json"
  },
  "ticker": "RVMD"
}